Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
The study examined the impact of varying prescription requirements for phosphodiesterase-5 inhibitors (PDE-5is) on the management of erectile dysfunction (ED) in men. A survey involving 10,000 men ...
The cell-surface glycoprotein TROP2 (also called TACSTD2) is increasingly recognized as a potential therapeutic target in advanced prostate cancer, owing to its membrane localization, maintained ...
UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback